Bariatric Surgery for Patients With Early-Onset vs Late-Onset Type 2 Diabetes.

IMPORTANCE The prevalence of early-onset type 2 diabetes mellitus (T2DM), which responds poorly to medical treatment, is increasing. Bariatric surgery has been well recognized for its effectiveness in the remission of T2DM, but its effectiveness and durability in the remission of early-onset T2DM has not yet been explored. OBJECTIVE To compare the short- and long-term outcomes of bariatric surgery with a specific focus on the rate of remission of T2DM in patients with early-onset (age <40 years) and late-onset (age ≥40 years) T2DM. DESIGN, SETTING, AND PARTICIPANTS In this cohort study, 558 Taiwanese patients (339 with early-onset T2DM and 219 with late-onset T2DM) with a body mass index (calculated as weight in kilograms divided by height in meters squared) above 25 underwent bariatric surgery to ameliorate T2DM between January 1, 2007, and December 31, 2013. Patients were followed up for at least 1 year. Preoperative, perioperative, and postoperative clinical and laboratory data were prospectively collected and compared between the 2 groups. MAIN OUTCOMES AND MEASURES Rate of remission of T2DM (hemoglobin A1C <6.0% without antiglycemic medication) was the primary outcome measure. RESULTS Of the 558 patients (345 women) in the study, mean (SD) ages were 33.5 (7.5) for those with early-onset T2DM and 50.6 (6.5) with late onset T2DM. Those with early-onset T2DM had higher mean (SD) preoperative BMI and hemoglobin A1C values (39.4 [8.5] and 8.7% [3.8%] of total hemoglobin [to convert hemoglobin to a proportion of total hemoglobin, multiply by 0.01], respectively) than did patients with late-onset T2DM (36.7 [7.5] and 8.2% [1.6%], respectively). Distribution of surgical procedures and major complications were similar between the 2 groups. At 1 year, patients with early-onset T2DM achieved greater weight loss than those with late-onset T2DM, although the difference was not statistically significant. A higher rate of complete remission of T2DM was observed in patients with early-onset T2DM than in those with late-onset disease (193 [56.9%] vs 110 [50.2%]; P = .02). At 5 years, patients with early-onset T2DM still maintained a higher rate of weight loss (mean [SD], 30.4% [11.8%] vs 21.6% [11.7%]; P = .002) and higher rate of remission (47 of 72 [65.3%] vs 26 of 48 [54.2%]; P = .04) than did those with late-onset disease. Age at bariatric surgery, duration of T2DM, and preoperative C-peptide level were independent predictors of remission. The remission rate was directly related to extent of weight loss. Multivariate analysis confirmed the higher rate of remission in the group with early-onset T2DM. CONCLUSIONS AND RELEVANCE This article describes the largest long-term study examining bariatric surgery for patients with early-onset T2DM. Bariatric surgery may achieve better and more long-lasting glycemic control in select patients with early-onset T2DM than in those with late-onset T2DM.

[1]  E. Gregg Obesity, diabetes, and the moving targets of healthy-years estimation. , 2015, The lancet. Diabetes & endocrinology.

[2]  R. Ozaki,et al.  Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. , 2014, The lancet. Diabetes & endocrinology.

[3]  R. Ozaki,et al.  Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. , 2014, The American journal of medicine.

[4]  Jasmin Divers,et al.  Prevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study , 2014, Diabetes Care.

[5]  F. Rubino,et al.  Bariatric, Metabolic, and Diabetes Surgery: What's in a Name? , 2014, Annals of surgery.

[6]  R. Ozaki,et al.  Prospective Study on the Incidences of Cardiovascular-Renal Complications in Chinese Patients With Young-Onset Type 1 and Type 2 Diabetes , 2013, Diabetes Care.

[7]  X. Ouyang,et al.  Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. , 2013, Diabetes research and clinical practice.

[8]  Avis J. Thomas,et al.  Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. , 2013, JAMA.

[9]  S. Caprio,et al.  Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes , 2013, Diabetes Care.

[10]  W. Tamborlane,et al.  Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial , 2013, Diabetes Care.

[11]  W. Tamborlane,et al.  Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes , 2013, Diabetes Care.

[12]  Wei-Jei Lee,et al.  Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[13]  S. Shaikh,et al.  Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[14]  P. Zimmet,et al.  Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[15]  J. Dixon,et al.  Predicting the Glycemic Response to Gastric Bypass Surgery in Patients With Type 2 Diabetes , 2012, Diabetes Care.

[16]  D. Nathan,et al.  A clinical trial to maintain glycemic control in youth with type 2 diabetes. , 2012, The New England journal of medicine.

[17]  D. Cummings,et al.  Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity , 2012, Diabetes Care.

[18]  F. Rubino,et al.  Bariatric surgery versus conventional medical therapy for type 2 diabetes. , 2012, The New England journal of medicine.

[19]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes. , 2012, The New England journal of medicine.

[20]  Jung-Chien Chen,et al.  Predictors of diabetes remission after bariatric surgery in Asia. , 2012, Asian journal of surgery.

[21]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[22]  F. Rubino,et al.  Bariatric surgery: an IDF statement for obese Type 2 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[23]  K. Harron,et al.  Rising Rates of All Types of Diabetes in South Asian and Non-South Asian Children and Young People Aged 0–29 Years in West Yorkshire, U.K., 1991–2006 , 2011, Diabetes Care.

[24]  L. Chuang,et al.  Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. , 2011, Archives of surgery.

[25]  Wei-Jei Lee,et al.  Experience in laparoscopic sleeve gastrectomy for morbidly obese Taiwanese: staple-line reinforcement is important for preventing leakage , 2010, Surgical Endoscopy.

[26]  Sonia Caprio,et al.  How Do We Define Cure of Diabetes? , 2009, Diabetes Care.

[27]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[28]  P. Wei,et al.  Gastrointestinal Quality of Life Following Laparoscopic Adjustable Gastric Banding in Asia , 2006, Obesity surgery.

[29]  P. Wei,et al.  Laparoscopic Roux-en-Y Versus Mini-Gastric Bypass for the Treatment of Morbid Obesity: A Prospective Randomized Controlled Clinical Trial , 2005, Annals of surgery.

[30]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[31]  T. Hillier,et al.  Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. , 2003, Diabetes care.

[32]  Y. Iwamoto,et al.  High Incidence of Diabetic Nephropathy in Early-Onset Japanese NIDDM Patients: Risk analysis , 1998, Diabetes Care.

[33]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[34]  Wei-Jei Lee,et al.  Gastrointestinal Metabolic Surgery for the Treatment of Diabetic Patients: A Multi-Institutional International Study , 2011, Journal of Gastrointestinal Surgery.